Home
Search
SurgiMabSurgiMab
  • Détection des tumeurs
  • Développement clinique
  • Société
    • L’équipe
    • Investisseurs
    • Partenaires
  • Actualités
  • Contact
  • Français
Laureate of the “Trophée Entrepreneur Santé” 2009
  • Détection des tumeurs
  • Développement clinique
  • Société
    • L’équipe
    • Investisseurs
    • Partenaires
  • Actualités
  • Contact
  • Français
EnglishEnglishFrançaisFrançais

Laureate of the “Trophée Entrepreneur Santé” 2009

SurgiMab > News & Events > News > Laureate of the “Trophée Entrepreneur Santé” 2009
18 April 2009 Administrateur SurgiMab0

SurgiMAb wins in the Heath Category.
SurgiMAb was designed by the jury of “Capital Transfert 2009” as the winner of the Trophy “Entrepreneur Santé” of the year.

After being chosen among the 18 pre-selected projects, Françoise Cailler received her Trophy from Mr. Philippe Adnot, Senator, during the closing ceremony of this event at Pitié Salpêtrière university of Medecine in Paris.

Next Post
SurgiMab raises 500 000 Euros to develop its products for intraoperative Immunophotodétection of tumors

Recent Posts

  • Françoise Cailler, CEO of surgiMab, will attend the WMIC2024 Congress in Montreal
  • SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam
  • SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 2023
  • SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.
  • SurgiMab will attend the 7th Annual International Congress for Fluorescence-Guided Surgery – Coral Gables, FL, 15th and 16th feb. 2020.
SurgiMab
Tumor detection Clinical development Company News & Events Contact

About SurgiMab

SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes.

Latest news

  • Françoise Cailler, CEO of surgiMab, will attend the WMIC2024 Congress in Montreal
  • SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam
Home | Legals, privacy & cookies (en) | Mentions légales, confidentialité & cookies (fr)
Copyright © 2025 SurgiMab. Website by B-to-B Design
Managing consent to cookies
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Failure to consent or withdrawal of consent may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or Internet user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Technical storage or access which is used exclusively for anonymous statistical purposes. In the absence of a subpoena, voluntary compliance by your internet service provider or additional records from a third party, information stored or retrieved for this sole purpose cannot generally be used to identify you.
Marketing
Storage or technical access is necessary to create profiles of Internet users in order to send advertisements, or to track the Internet user on a website or on several websites with similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}